Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2010
10/14/2010US20100260829 Sustained Release of Antiinfectives
10/14/2010US20100260827 Methods of diagnosing, preventing and treating cancer metastasis
10/14/2010US20100260825 Antifolates for the treatment of cardiovascular, inflammatory, neoplastic, autoimmune and related diseases in sublingual dosage units, film strips, or skin patches
10/14/2010US20100260824 Antimicrobial Foam Compositions, Articles and Methods
10/14/2010US20100260819 Reducing post-operative adhesion formation with intraperitoneal glutamine
10/14/2010US20100260818 Stable medicated chewing gum comprising cyclodextrin inclusion complex
10/14/2010US20100260817 Polyamine Derivatives
10/14/2010US20100260813 Rodenticide Mixture
10/14/2010US20100260811 Novel compositions of fat-soluble substances
10/14/2010US20100260810 Antidepressant dosage form
10/14/2010US20100260809 Preparation For Wound Healing And Prevention Of Bandage Adhesion To The Wound, Containing Chitosan-Glucan
10/14/2010US20100260807 Methods of Inducing and/or Enhancing an Immune Response To Tumor Antigens
10/14/2010US20100260806 Nucleic acids
10/14/2010US20100260788 Immune Stimulatory Oligoribonucleotide Analogs Containing Modified Oligophosphate Moieties
10/14/2010US20100260784 Pai-1 binding modulators for the treatment of ocular disorders
10/14/2010US20100260781 Treatment methods for autoimmune disorders
10/14/2010US20100260778 Small-molecule botulinum toxin inhibitors
10/14/2010US20100260777 Treatment and/or prevention of sepsis using an enteral composition
10/14/2010US20100260774 Netrin-1 Compositions and Methods of Use Thereof
10/14/2010US20100260772 Methods for treating or preventing diseases associated with low bone mass
10/14/2010US20100260771 Method for Diagnosing the Metabolic Syndrome (MS)
10/14/2010US20100260757 USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY
10/14/2010US20100260755 Ibudilast and immunomodulators combination
10/14/2010US20100260753 Aminoflavone (nsc 686288) and combinations thereof for treating breast cancer
10/14/2010US20100260750 Novel serotonin reuptake inhibitors as drugs having peripheral-system-restricted activity
10/14/2010US20100260749 Modulators of EphA2 and Ephrin-A1 for the treatment of fibrosis-related disease
10/14/2010US20100260747 Use of Tetrahydrobiopterin as a Marker and a Therapeutic Agent for Fabry Disease
10/14/2010US20100260746 Novel Bank1 Splice Variant
10/14/2010US20100260743 Solubilization and Targeted Delivery of Drugs With Self-Assembling Amphiphilic Polymers
10/14/2010US20100260740 Methods for preventing and/or treating lysosomal storage disorders
10/14/2010US20100260738 Uses and methods relating to ndr kinase expression and/or activity
10/14/2010US20100260737 Combination between an isothiocyanate and levodopa for parkinson's disease treatment
10/14/2010US20100260735 Methods for promoting plant health
10/14/2010US20100260733 Novel anti aging agents and methods to identify them
10/14/2010US20100260719 Methods for treatment of hepatocellular carcinoma using 3-(4-amino-1-oxo-1,3-dihydroisoindol-2-yl)-piperidine-2,6-dione
10/14/2010US20100260718 Irf-4 as a tumor suppressor and uses thereof
10/14/2010US20100260717 Methods of treating a flaviviridae family viral infection, compositions for treating a flaviviridae family viral infection, and screening assays for identifying compositions for treating a flaviviridae family viral infection
10/14/2010US20100260716 Compounds for treating demyelination conditions
10/14/2010US20100260715 Hepatitis c virus inhibitors
10/14/2010US20100260714 Compositions comprising n3 alkylated benzimidazole derivatives as mek inhibitors and methods of use thereof
10/14/2010US20100260713 Compositions and Methods for the Inhibition of Hepatitis C Viral Replication with Structural Analogs
10/14/2010US20100260711 3-aminosulfonyl substituted indole derivatives and methods of use thereof
10/14/2010US20100260710 Macrocyclic serine protease inhibitors
10/14/2010US20100260709 Organic compounds and their uses
10/14/2010US20100260708 Hepatitis C Virus Inhibitors
10/14/2010US20100260703 Injectable biodegradable polymer compositions for soft tissue repair and augmentation
10/14/2010US20100260702 Bioabsorbable and biocompatible polyurethanes and polyamides for medical devices
10/14/2010US20100260688 New Formulation and Use Thereof
10/14/2010US20100260676 Precision-guided nanoparticle systems for drug delivery
10/14/2010US20100260675 Oxytocin Receptor Antagonists and Their Use for the Treatment of Pulmonary Related Diseases
10/14/2010US20100260674 Quinazoline derivatives and methods of treatment
10/14/2010US20100260671 Compounds and methods for the diagnosis and treatment of amyloid associated diseases
10/14/2010US20100260669 Treatment of Seasonal Conditions Through Modulation of the Autonomic Nervous System
10/14/2010DE202010010589U1 Estrogenfreie Formulierung zur oralen Kontrazeption, bevorzugt verwendbar für Frauen mit bewusster/unbewusster Laktoseintoleranz oder mit bewusster laktosefreier Kontrazeption Estrogen-free formulation for oral contraception, preferably suitable for women with conscious / unconscious lactose intolerance or lactose-free contraception with conscious
10/14/2010DE202010010189U1 Koffeinhaltige Konzentratlösung in einer Trägerflüssigkeit die mit einem speziellen elektrisch betriebenem einer Zigarette ähnlichem Gerät thermisch verdampft werden kann und dieser koffeinhaltige Dampf inhaliert werden kann Caffeine-containing concentrate solution in a carrier liquid the like with a special an electrically operated cigarette device can be thermally evaporated and this caffeinated vapor can be inhaled
10/14/2010DE10337458B4 Verbesserungen bei der Extraktion von pharmazeutisch aktiven Komponenten aus Pflanzenmaterialien Improvements in the extraction of pharmaceutically active components from plant materials
10/14/2010DE102009016719A1 Composition, useful as pharmaceutical preparation for e.g. prophylaxis of lipid metabolic disorders in humans and animals and treating atherosclerosis, comprises 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor and solid material
10/14/2010DE102009015917A1 Use of an active agent comprising resveratrol, thymol, xanthohumol or vitamin C for inhibition and/or prophylaxis of e.g. eryptosis, acute renal failure, anemia, shock, atherosclerosis, thrombosis, diabetes mellitus and sickle cell anemia
10/14/2010DE102009015070A1 New phenyl-pyrimidin-2-yl-amine compounds are tyrosine kinase 2 inhibitors useful for treating e.g. rheumatoid arthritis, Crohn's disease, asthma, multiple sclerosis, adult respiratory distress syndrome, allergic alveolitis and uveitis
10/14/2010DE102009002268A1 Use of 4,4'-dihydroxydeoxybenzoin compound for masking or reducing unpleasant taste of an unpleasant tasting material, and/or strengthening the sweet tasting material of sweet material
10/14/2010CA2795907A1 Methods and compositions for inducing physiological hypertrophy
10/14/2010CA2761634A1 Mitochondrial function-improving agent
10/14/2010CA2758300A1 Checkpoint kinase 1 inhibitors for potentiating dna damaging agents
10/14/2010CA2758271A1 Methods for preventing and/or treating lysosomal storage disorders
10/14/2010CA2758253A1 Control of concentric tubing direction
10/14/2010CA2758251A1 Serotonin and norepinephrine reuptake inhibitor
10/14/2010CA2758234A1 Therapeutic applications in the cardiovascular field of quinazolinedione derivatives
10/14/2010CA2758233A1 Quinazolinedione derivatives, preparation thereof and various therapeutic uses thereof
10/14/2010CA2758204A1 Immunogenic composition and uses thereof
10/14/2010CA2758200A1 Nanoparticle formulations and uses thereof
10/14/2010CA2758189A1 Tricyclo-dna antisense oligonucleotides, compositions, and methods for the treatment of disease
10/14/2010CA2758187A1 Methods for preventing and/or treating degenerative disorders of the central nervous system
10/14/2010CA2758172A1 A plant extract comprising statins and preparation techniques and uses thereof
10/14/2010CA2758149A1 Inhibitors of hiv replication
10/14/2010CA2758146A1 Organic compounds and their uses
10/14/2010CA2758144A1 Cyclic compound having substituted phenyl group
10/14/2010CA2758105A1 Indane derivatives
10/14/2010CA2758100A1 Process for preparing pyrrolidinium salts
10/14/2010CA2758071A1 Therapeutic compositions and related methods of use
10/14/2010CA2758047A1 Hepatitis c virus inhibitors
10/14/2010CA2758019A1 Imidaz0[1,2-a] pyridine-6-carboxamide derivatives, their use for the treatment of colon cancer and their method of manufacture
10/14/2010CA2757998A1 Methods of treating edema related to ischemia-reperfusion
10/14/2010CA2757988A1 Active pharmaceutical ingredient adsorbed on solid support
10/14/2010CA2757986A1 Non-pegylated liposomal doxorubicin triple combination therapy
10/14/2010CA2757979A1 Controlled-release clozapine compositions
10/14/2010CA2757963A1 Hepatitis c virus inhibitors
10/14/2010CA2757934A1 Crystal forms of saxagliptin
10/14/2010CA2757912A1 Compounds that suppress cancer cells and exhibit antitumor activity
10/14/2010CA2757879A1 Isoxazol-3(2h)-one analogs as therapeutic agents
10/14/2010CA2757859A1 Substituted 1-alkylcinnolin-4(1h)-one derivatives, preparation thereof and therapeutic application of same
10/14/2010CA2757858A1 Improved glucocorticoid therapy
10/14/2010CA2757752A1 Process for producing rapidly disintegrating spheroids (pellets), granules and/or mixtures thereof
10/14/2010CA2757745A1 Combination of cytidine-based antineoplastic drugs with cytidine deaminase inhibitor and use thereof in the treatment of cancer
10/14/2010CA2757744A1 Combination of decitabine with cytidine deaminase inhibitor and use thereof in the treatment of cancer
10/14/2010CA2757743A1 (2'-deoxy-ribofuranosyl)-1,3,4,7-tetrahydro-(1,3) diazepin-2-0ne derivatives for treating cancer
10/14/2010CA2757723A1 Method of predicting a predisposition to qt prolongation based on abcc2 gene sequence or product thereof
10/14/2010CA2757713A1 Method of treatment based on polymorphisms of the kcnq1 gene
10/14/2010CA2757685A1 6'-sialyllactose salts and process for their synthesis and for the synthesis of other a-sialyloligosaccharides
10/14/2010CA2757679A1 Inhibitors of fatty acid amide hydrolase
10/14/2010CA2757654A1 Sulfonic amide and sulfoximine-substituted diaryl-dihydropyrimidinones and usage thereof
1 ... 2050 2051 2052 2053 2054 2055 2056 2057 2058 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 ... 7860